Publications
47 publications
Funding
10 grantsView NIH portfolio on RePORTER ↗
Active
4 grants- Co-IR01CA275846-01Cholesterol Metabolism in Mesenchymal Colorectal CancerNational Cancer Institute · 2022–2027
- PIR50CA265332-05Dissecting the in vivo stromal metabolic and inflammatory crosstalk in colorectal cancerNational Cancer Institute · 2022–2027
- Co-IR01CA265892-01Interferon regulation by NBR1-driven chaperone-mediated autophagy in stellate cells in liver cancerNational Cancer Institute · 2021–2027
- Co-IR01CA250025-01A1Molecular mechanisms driving mesenchymal colorectal cancerNational Cancer Institute · 2021–2026
Completed grants (6)
- MPIR01CA246765-01Novel Pathways in the Control of Lineage Plasticity in Neuroendocrine Prostate CancerNational Cancer Institute · 2020–2025
- PISA 234307-01Study of tumor microenvironment in colorectal cancer using multiplex IF and IHC staining of mouse models.The University of Luxembourg · 2023–2023Contract
- MPIR01CA218254-04Role of p62 in metabolic reprograming of the tumor stroma in prostate cancerNational Cancer Institute · 2020–2022
- Co-IR01DK108743-05Control of stellate cells-driven liver cancer by the p62/NBR1 adaptersNational Institute of Diabetes and Digestive and Kidney Diseases · 2020–2022
- Co-IR01CA207177-04Mechanisms of cell death and autophagy in intestinal epithelial cells in inflammation and cancerNational Cancer Institute · 2020–2022
- MPIR01CA211794-05Role of p62/SQSTM1 in obesity-induced liver cancerNational Cancer Institute · 2020–2022 · via University of California, San Diego